|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| C07D 205/04 | (2013.01) | ||
| C07D 405/04 | (2006.01) | ||
| C07D 401/04 | (2013.01) | ||
| C07D 205/04 | (2006.01) | ||
| C07D 405/04 | (2013.01) | ||
| A61K 31/397 | (2006.01) | ||
| A61P 31/06 | (2006.01) |
| (11) | Number of the document | 3668854 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18752499.6 |
| Date of filing the European patent application | 2018-08-15 | |
| (97) | Date of publication of the European application | 2020-06-24 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/072145 |
| Date | 2018-08-15 |
| (87) | Number | WO 2019/034702 |
| Date | 2019-02-21 |
| (30) | Number | Date | Country code |
| 17382571 | 2017-08-16 | EP |
| (72) |
PORRAS DE FRANCISCO, Esther , ES
REMUIÑAN-BLANCO, Modesto Jesús , ES
BOUROTTE, Marilyne , FR
DEPREZ, Benoit , FR
DEQUIREZ, Geoffroy , FR
WILLAND, Nicolas , FR
|
| (73) |
GlaxoSmithKline Intellectual Property Development
Limited ,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
Bioversys AG , Hochbergerstrasse 60c, 4057 Basel, CH |
| (54) | NOVEL COMPOUNDS |
| NOVEL COMPOUNDS |